HomePBM • NASDAQ
Psyence Biomedical Ltd
add
$11.50
15.12%
After Hours:(4.35%)-0.50
$11.00
Closed: Jul 25, 4:02:44 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 864.94K | 34.28% |
Net income | -974.43K | 96.07% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -863.70K | -34.10% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.14M | 736.78% |
Total assets | 7.32M | 546.23% |
Total liabilities | 594.37K | -95.09% |
Total equity | 6.72M | — |
Shares outstanding | 71.27K | — |
Price to book | 0.11 | — |
Return on assets | -29.55% | — |
Return on capital | -32.17% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -974.43K | 96.07% |
Cash from operations | -1.11M | -63.45% |
Cash from investing | -4.90K | -71.12% |
Cash from financing | 3.22M | 331.41% |
Net change in cash | 2.10M | 3,190.82% |
Free cash flow | -663.50K | -183.53% |
Previous close
$9.99
Day range
$10.00 - $11.99
Year range
$2.92 - $699.19
Market cap
8.20M USD
Avg Volume
73.61K
P/E ratio
0.28
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2023
Headquarters
Website
Employees
12